Simulations Plus, Inc.
-
Ticker
SLP
-
Industry
Healthcare Information Services More
-
Sector
Healthcare More
- 51-200 Employees
- Based in Lancaster, California
Simulations Plus, Inc. (NASDAQ: SLP) is the premier developer of modeling & simulation software and consulting services supporting drug discovery, development research and regulatory submissions. They partner with companies to provide a data-driven, ‘strategic modeling methodology’, starting in early discovery, continuing through preclinical/clinical development, and concluding with clinical
…More trials/post approval. With their subsidiaries, Cognigen Corporation and DILIsym Services, they offer #1-ranked, easy-to-use software (GastroPlus®, ADMET Predictor®, KIWI™, DILIsym®, NAFLDsym®, PKPlus™, and more) to bridge data mining, compound library screening with QSAR models, PBPK/TK modeling & simulation in animals and humans following administration around the body, and quantitative systems pharmacology approaches. Simulations Plus technology is licensed to and used by regulatory agencies worldwide.
REPORT RATINGS
4.8 / 5.0 (108)
Simulations Plus, Inc. reports have an aggregate usefulness score of 4.8 based on 108 reviews.
Simulations Plus, Inc.
Most Recent Responsibility Report
MOST RECENT
2020 Environmental, Social, and Governance Report
Report Locked. Simulations Plus, Inc. has reached its limit for free report views.
Our service enables potential investors to review the most recent and archived Simulations Plus, Inc. Sustainability Report, Simulations Plus, Inc. Corporate Social Responsibility Report, Simulations Plus, Inc. CSR Report, Simulations Plus, Inc. Corporate Responsibility, Simulations Plus, Inc. CR Report, Simulations Plus, Inc. Citizenship Report, Simulations Plus, Inc. ESG Report, and Simulations Plus, Inc. Environmental Report online.